Edesa Biotech, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/13/2023 | 1.28 M | $809,981 | 0.00% | 6.25% |
CM MANAGEMENT, LLC | 11/07/2023 | 417,602 | $263,924 | 11.36% | 2.04% |
VANGUARD GROUP INC | 12/18/2023 | 110,862 | $70,065 | -0.02% | 0.54% |
GEODE CAPITAL MANAGEMENT, LLC | 11/13/2023 | 102,790 | $64,263 | 18.56% | 0.50% |
CIBC WORLD MARKET INC. | 11/13/2023 | 54,626 | $239,000 | 0.00% | 0.27% |
STATE STREET CORP | 11/14/2023 | 43,975 | $27,484 | 0.00% | 0.21% |
NORTHERN TRUST CORP | 11/13/2023 | 22,540 | $14,245 | 0.00% | 0.11% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2023 | 8,521 | $5,385 | 0.00% | 0.04% |
UBS GROUP AG | 11/09/2023 | 5,436 | $3,436 | 16,372.73% | 0.03% |
ROYAL BANK OF CANADA | 11/14/2023 | 1,375 | $1,000 | 0.00% | 0.01% |
TD WATERHOUSE CANADA INC. | 11/13/2023 | 1,000 | $665 | 0.00% | 0.00% |
FIFTH THIRD BANCORP | 10/31/2023 | 700 | $442 | 0.00% | 0.00% |
BLACKROCK INC. | 11/13/2023 | 518 | $327 | 0.00% | 0.00% |
MORGAN STANLEY | 11/15/2023 | 200 | $126 | 100.00% | 0.00% |
GLOBAL RETIREMENT PARTNERS, LLC | 10/13/2023 | 175 | $110 | 0.00% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/15/2024 | 135 | $85 | 0.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 11/13/2023 | 108 | $68 | -7.69% | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 10/10/2023 | 60 | $40 | 7.14% | 0.00% |
ALLSQUARE WEALTH MANAGEMENT LLC | 11/27/2023 | 10 | $6 | 0.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2023 | 8 | $5 | 0.00% | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 11/09/2023 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA INVESTMENTS, LP | 11/14/2023 | 0 | $0 | -100.00% | 0.00% |
CREDIT AGRICOLE S A | 11/14/2023 | 0 | $0 | -100.00% | 0.00% |
Edesa Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Edesa Biotech, Inc.. The most heavily invested institutionals were:
Advisor Group, Inc.: 128
LADENBURG THALMANN FINANCIAL SERVICES INC.: 11
10.00% of Edesa Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 139 shares in the last 24 months. This purchase volume represents approximately $263 in transactions.